Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
COMPASS Pathways Plc - American Depository Shares
(NQ:
CMPS
)
4.620
+0.060 (+1.30%)
Streaming Delayed Price
Updated: 12:05 PM EST, Nov 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about COMPASS Pathways Plc - American Depository Shares
< Previous
1
2
...
22
23
24
25
26
27
28
29
Next >
Psychedelic Stock Gainers And Losers From March 1, 2022
March 01, 2022
GAINERS: Cybin (AMEX:
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 28, 2022
February 28, 2022
GAINERS: Wellbeing Digital (OTC:
Via
Benzinga
Psychedelic & Marijuana Drug Stocks Continue To Decline
February 27, 2022
This article updates the latest stock performances of the 13 clinical-stage companies with the largest market capitalizations which are tracked in the munKNEE Pure-Play Marijuana (4) and the munKNEE...
Via
Talk Markets
Field Trip Health, Seelos Therapeutics Among Top Psychedelic Movers Of Today
February 25, 2022
GAINERS: Field Trip Health (NASDAQ:
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 24, 2022
February 24, 2022
GAINERS: Seelos Therapeutics (NASDAQ:
Via
Benzinga
COMPASS Pathways Posts Wider Net Loss In Q4, Gives Update On Psilocybin Research
February 24, 2022
COMPASS Pathways plc (NASDAQ:CMPS) reported its fi...
Via
Benzinga
Small Pharma, GH Research Among Top Psychedelic Movers Of Today
February 23, 2022
GAINERS: Small Pharma (OTC:
Via
Benzinga
Compass Pathways Earnings Preview
February 23, 2022
Compass Pathways (NASDAQ:CMPS) is set to give its latest quarterly earnings report on Thursday, 2022-02-24. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 22, 2022
February 22, 2022
GAINERS: LOSERS: Mindset Pharma (OTC:
Via
Benzinga
Psychedelic & Marijuana Drug Stocks Continued To Decline Last Week
February 21, 2022
An update on the stock performances of the 13 clinical-stage psychedelic and marijuana drug companies with the largest market capitalizations.tttttttttt
Via
Talk Markets
Field Trip Health, Mind Medicine Among Top Psychedelic Movers Of Today
February 18, 2022
GAINERS: Field Trip Health (NASDAQ:
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 17, 2022
February 17, 2022
GAINERS: Mindset Pharma (OTC:
Via
Benzinga
Magic Mushroom's Active Compound Could Relieve Depression For Up To One Year, New Study Finds
February 16, 2022
A new review study by Johns Hopkins University researchers is shedding light on the long-term effects of psilocybin in the treatment of maj...
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 15, 2022
February 15, 2022
GAINERS: Mind Medicine (NASDAQ:
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 14, 2022
February 14, 2022
GAINERS: Wellbeing Digital (OTC:
Via
Benzinga
Psychedelic And Cannabis Drug Stocks Continue Advance
February 13, 2022
This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses.
Via
Talk Markets
Mind Medicine, Cybin Among Top Psychedelic Movers Of Today
February 11, 2022
GAINERS: Revive Therapeutics (OTC: RVVTF) shares closed up 2.51% at $0.22 LOSERS: Mind Medicine (NASDAQ: MNMD) shares closed down 8.09% at $1.25 Cybin (AMEX:CYBN) shares closed down 6.25% at $1.05 ATAI...
Via
Benzinga
Allied, Cybin Among Top Psychedelic Movers Of Today
February 10, 2022
GAINERS: Allied (OTC:ALID) shares closed up 7.39% at $1.89
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 9, 2022
February 09, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 14.29% at $5.76
Via
Benzinga
Cathie Wood Is Buying this Peter Thiel-Backed Psychedelics Stock For Ark Funds
February 09, 2022
There’s a new psychedelics company being added to an ETF from Cathie Wood. What Happened: The Ark Genomic Revolution ETF (BATS: ARKG) took an initial position in shares of...
Via
Benzinga
Mindset Pharma, Cybin Among Top Psychedelic Movers Of Today
February 08, 2022
GAINERS: Awakn Life Sciences (OTC:AWKNF) shares closed up 3.51% at $1.62
Via
Benzinga
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today
February 07, 2022
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 9.82% at $1.23
Via
Benzinga
Is The Psychedelics Sector In Decline? This $30M VC Fund Says HOLD
February 07, 2022
This article was originally published on Microdose and appears here with permission. Recently, there has been an exciting discussion in LinkedIn posts and Microdose PsyCap events regarding the presumed...
Via
Benzinga
Small Pharma, Mind Medicine Among Top Psychedelic Movers Of Today
February 04, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 7.29% at $0.20
Via
Benzinga
Field Trip Health, Seelos Therapeutics Among Top Psychedelic Movers Of Today
February 03, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 6.29% at $0.19
Via
Benzinga
Mind Medicine, Allied Among Top Psychedelic Movers Of Today
February 02, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 5.04% at $0.17
Via
Benzinga
New Psychedelics ETF Launches On NYSE Arca
February 02, 2022
Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to address medical conditions. The PSYK ETF (NYSE: PSYK)...
Via
Benzinga
Mindset Pharma, Allied Among Top Psychedelic Movers Of Today
February 01, 2022
GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 15.70% at $0.69
Via
Benzinga
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today
January 31, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 7.89% at $5.33
Via
Benzinga
Has A Sugar Daddy Emerged In The Psychedelic Drug Industry?
January 31, 2022
One very large drug multinational has already been active in writing checks to finance drug development in the psychedelic drug industry.
Via
Talk Markets
< Previous
1
2
...
22
23
24
25
26
27
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.